Back to search
FDAFDA · Food and drugs·Recall number Z-2248-2020

safeCLINITUBES Blood Sampler;REF 942-898;D957P-70-70x1

Published June 10, 2020 · Recall initiated: March 17, 2020

Summary

FDA records medical device Class II recall Z-2248-2020, published June 10, 2020 and initiated March 17, 2020. Recalling firm: Radiometer Medical ApS; Status: Terminated; Reported quantity: 269 units; Lot: Lot numbers: R1431 - R1495. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The SafeCLINITUBES blood sampler may have insufficient aspiration capabilities ultimately resulting in lost samples.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Radiometer Medical ApS
Distributor
U.S.: AK, AL, AR, CA, CO, CT, FL,GA, IA, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OR, PA, SD, TN, TX, UT, VA, WA, and WI. OUS: Australia (New Zealand), Austria, Brazil Canada, China, Czech Republic (Slovakia), Denmark, Dubai (United Arab Emirates), Egypt, Finland, France, Germany, Hong Kong, Hungary, Iceland, India, Ireland, Italy, Japan, Kazakhstan, Lithuania, Malawi, Malaysia, Mauritius, Netherlands (Belgium), Nicaragua, Norway, Poland, Portugal, Russia, Saudi Arabia, Serbia, South Africa, Spain, Sweden, Switzerland, Turkey (Cyprus), and United Kingdom.
Lot
Lot numbers: R1431 - R1495
Risk classification
Class II
Area (FDA)
device
Country
Denmark

Related recalls

Questions about this recall

Was safeCLINITUBES Blood Sampler;REF 942-898;D957P-70-70x1 recalled?

Yes. FDA published recall Z-2248-2020 on June 10, 2020. Reported hazard: The SafeCLINITUBES blood sampler may have insufficient aspiration capabilities ultimately resulting in lost samples.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail